US Patent Issued to PLEIOGENIX on Dec. 2 for "Methods of treating fibrotic liver diseases or conditions with indeglitazar" (Missouri, California Inventors)

ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,106, issued on Dec. 2, was assigned to PLEIOGENIX INC. (Carlsbad, Calif.).

"Methods of treating fibrotic liver diseases or conditions with indeglitazar" was invented by Prasad Manchem (Carlsbad, Calif.) and Joseph L. Evans (Saint Louis, Mo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods of treating metabolic dysfunction-associated steatohepatitis (MASH) in a human subject, comprising administering to the subject a therapeutically effective amount of indeglitazar or a pharmaceutically acceptable salt thereof."

The patent was filed on Feb. 28, 2025, under Application No. 19/067,616.

*For further information, i...